APA (7th ed.) Citation

M, C., J, V., IA, V., K, S., S, M., L, P., . . . G, R. (2026). Therapeutic sequencing and role of cabozantinib after immunotherapy in metastatic renal cell carcinoma. Critical reviews in oncology/hematology, 223, 105334. https://doi.org/10.1016/j.critrevonc.2026.105334

Chicago Style (17th ed.) Citation

M, Catalano, et al. "Therapeutic Sequencing and Role of Cabozantinib After Immunotherapy in Metastatic Renal Cell Carcinoma." Critical Reviews in Oncology/hematology 223 (2026): 105334. https://doi.org/10.1016/j.critrevonc.2026.105334.

MLA (9th ed.) Citation

M, Catalano, et al. "Therapeutic Sequencing and Role of Cabozantinib After Immunotherapy in Metastatic Renal Cell Carcinoma." Critical Reviews in Oncology/hematology, vol. 223, 2026, p. 105334, https://doi.org/10.1016/j.critrevonc.2026.105334.